• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT HIV AG/AB COMBO REAGENT KIT; TEST, HIV DETECTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT HIV AG/AB COMBO REAGENT KIT; TEST, HIV DETECTION Back to Search Results
Catalog Number 04J27-84
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/01/2023
Event Type  malfunction  
Event Description
The customer observed false nonreactive architect hiv ag/ab combo results for one patient who tested positive by another method.The samples were retested, and the results remained nonreactive.The following data was provided: on (b)(6) 2023 architect hiv ag/ab combo result= nonreactive; repeat result= nonreactive.On (b)(6) 2023 architect hiv ag/ab combo result= nonreactive; repeat result= nonreactive.On (b)(6) 2023 roche result= positive.No impact to patient management was reported.
 
Manufacturer Narrative
This report is being filed on an international product, list number 04j27-84 (architect hiv ag/ab combo) that has a similar product distributed in the us, list number(b)(4).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Manufacturer Narrative
The complaint investigation for false nonreactive architect hiv ag/ab combo result included a review of data and information provided by the customer, search for similar complaints, ticket trending review, device history record review, and labeling review.In-house testing of retained reagent kit was also completed.Return testing was not performed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue.Ticket search by lot indicates that the reagent lot performs as expected for this product.Trending review did not identify any trends for the issue for the product.Device history record review did not identify any non-conformances or deviations with the likely cause lot number and complaint issue.Labeling was reviewed and found to be adequate.In-house testing of a retained reagent kit of the lot 56082be00 was performed.All specifications were met, and no false nonreactive results were obtained, showing that the lot generates the expected results.In addition, the clinical sensitivity was evaluated by testing two commercially available seroconversion panels (zeptometrix hiv 9013 and hiv 9016).The seroconversion panel results were compared to architect hiv test results provided by zeptometrix and the reagent lot detected the same bleeds as reactive.Based on these data, it was shown that the sensitivity performance of the lot is not adversely affected.Based on our investigation, no systemic issue or deficiency with the architect hiv ag/ab combo reagent for lot 56082be00 was identified.The following sections have been corrected to reflect the current contact (b)(6).
 
Event Description
The customer observed false nonreactive architect hiv ag/ab combo results for one patient who tested positive by another method.The samples were retested, and the results remained nonreactive.The following data was provided: (b)(6) 2023 architect hiv ag/ab combo result = nonreactive; repeat result = nonreactive.(b)(6) 2023 architect hiv ag/ab combo result = nonreactive; repeat result = nonreactive.(b)(6) 2023 roche result = positive.No impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HIV AG/AB COMBO REAGENT KIT
Type of Device
TEST, HIV DETECTION
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key17716892
MDR Text Key323898280
Report Number3002809144-2023-00389
Device Sequence Number1
Product Code MZF
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/03/2024
Device Catalogue Number04J27-84
Device Lot Number56082BE00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/21/2023
Initial Date FDA Received09/10/2023
Supplement Dates Manufacturer Received11/08/2023
Supplement Dates FDA Received11/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/18/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2000SR INST, 03M74-02, (B)(6).; ARC I2000SR INST, 03M74-02, (B)(6).
-
-